| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 44.777 | 1.111 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 44.877 | 1.084 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 41.962 | 2.760 | 686 | 579 | 0 | 490 | 0 | 0 | 31 | 0 |
| Gross Profit/Loss - EUR | 2.915 | -1.677 | -686 | -579 | 0 | -490 | 0 | 0 | -31 | 0 |
| Net Profit/Loss - EUR | 1.569 | -1.710 | -686 | -579 | 0 | -490 | 0 | 0 | -31 | 0 |
| Employees | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Neoclinique New Dentistry Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 4.992 | 230 | -46 | -102 | -100 | -72 | -70 | -70 | -101 | -101 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | -1 | 0 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 |
| Cash | 4.993 | 230 | -45 | -101 | -99 | -71 | -69 | -69 | -100 | -100 |
| Shareholders Funds | 1.614 | -112 | -797 | -1.361 | -1.335 | -1.800 | -1.760 | -1.765 | -1.791 | -1.781 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.385 | 342 | 751 | 1.259 | 1.235 | 1.729 | 1.690 | 1.695 | 1.690 | 1.681 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Neoclinique New Dentistry Srl